Erin Nealon1, Brian K Rivera2, Clifford L Cua1, Molly K Ball3, Corey Stiver1, Brian A Boe1, Jonathan L Slaughter4, Joanne Chisolm5, Charles V Smith6, Jennifer N Cooper7, Aimee K Armstrong1, Darren P Berman1, Carl H Backes8. 1. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; The Heart Center, Nationwide Children's Hospital, Columbus, OH. 2. Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH. 3. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; Department of Neonatology, Nationwide Children's Hospital, Columbus, OH. 4. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH; Department of Neonatology, Nationwide Children's Hospital, Columbus, OH; Division of Epidemiology, The Ohio State University College of Public Health, Columbus, OH. 5. The Heart Center, Nationwide Children's Hospital, Columbus, OH. 6. University of Washington School of Medicine, Seattle, WA. 7. Division of Epidemiology, The Ohio State University College of Public Health, Columbus, OH; Center for Surgical Outcomes, The Research Institute at Nationwide Children's Hospital, Columbus, OH. 8. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; The Heart Center, Nationwide Children's Hospital, Columbus, OH; Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH; Department of Neonatology, Nationwide Children's Hospital, Columbus, OH. Electronic address: carl.backesjr@nationwidechildrens.org.
Abstract
OBJECTIVES: To describe longer term outcomes for infants <6 kg undergoing percutaneous occlusion of the patent ductus arteriosus (PDA). STUDY DESIGN: This was a retrospective cohort study of infants <6 kg who underwent isolated percutaneous closure of the PDA at a single, tertiary center (2003-2017). Cardiopulmonary outcomes and device-related complications (eg, left pulmonary artery obstruction) were examined for differences across weight thresholds (very low weight, <3 kg; low weight, 3-<6 kg). We assessed composite measures of respiratory status during and beyond the initial hospitalization using linear mixed effects models. RESULTS: In this cohort of lower weight infants, 92 of 106 percutaneous occlusion procedures were successful. Median age and weight at procedure were 3.0 months (range, 0.5-11.1 months) and 3.7 kg (range, 1.4-5.9 kg), respectively. Among infants with pulmonary artery obstruction on initial postprocedural echocardiograms (n = 20 [22%]), obstruction persisted through hospital discharge in 3 infants. No measured variables were associated with device-related complications. Rates of oxygenation failure (28% vs 8%; P < .01) and decreased left ventricular systolic function (29% vs 5%; P < .01) were higher among very low weight than low weight infants. Pulmonary scores decreased (indicating improved respiratory status) following percutaneous PDA closure. CONCLUSIONS: Percutaneous PDA occlusion among lower weight infants is associated with potential longer term improvements in respiratory health. Risks of device-related complications and adverse cardiopulmonary outcomes, particularly among very low weight infants, underscore the need for continued device modification. Before widespread use, clinical trials comparing percutaneous occlusion vs alternative treatments are needed.
OBJECTIVES: To describe longer term outcomes for infants <6 kg undergoing percutaneous occlusion of the patent ductus arteriosus (PDA). STUDY DESIGN: This was a retrospective cohort study of infants <6 kg who underwent isolated percutaneous closure of the PDA at a single, tertiary center (2003-2017). Cardiopulmonary outcomes and device-related complications (eg, left pulmonary artery obstruction) were examined for differences across weight thresholds (very low weight, <3 kg; low weight, 3-<6 kg). We assessed composite measures of respiratory status during and beyond the initial hospitalization using linear mixed effects models. RESULTS: In this cohort of lower weight infants, 92 of 106 percutaneous occlusion procedures were successful. Median age and weight at procedure were 3.0 months (range, 0.5-11.1 months) and 3.7 kg (range, 1.4-5.9 kg), respectively. Among infants with pulmonary artery obstruction on initial postprocedural echocardiograms (n = 20 [22%]), obstruction persisted through hospital discharge in 3 infants. No measured variables were associated with device-related complications. Rates of oxygenation failure (28% vs 8%; P < .01) and decreased left ventricular systolic function (29% vs 5%; P < .01) were higher among very low weight than low weight infants. Pulmonary scores decreased (indicating improved respiratory status) following percutaneous PDA closure. CONCLUSIONS: Percutaneous PDA occlusion among lower weight infants is associated with potential longer term improvements in respiratory health. Risks of device-related complications and adverse cardiopulmonary outcomes, particularly among very low weight infants, underscore the need for continued device modification. Before widespread use, clinical trials comparing percutaneous occlusion vs alternative treatments are needed.
Authors: Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi Journal: J Am Soc Echocardiogr Date: 2002-02 Impact factor: 5.251
Authors: John M Costello; Angelo Polito; David W Brown; Thomas F McElrath; Dionne A Graham; Ravi R Thiagarajan; Emile A Bacha; Catherine K Allan; Jennifer N Cohen; Peter C Laussen Journal: Pediatrics Date: 2010-07-05 Impact factor: 7.124
Authors: Srinath T Gowda; Shelby Kutty; Makram Ebeid; Athar M Qureshi; Sarah Worley; Larry A Latson Journal: Pediatr Cardiol Date: 2009-04-14 Impact factor: 1.655
Authors: Megan Barcroft; Christopher McKee; Darren P Berman; Rachel A Taylor; Brian K Rivera; Charles V Smith; Jonathan L Slaughter; Afif El-Khuffash; Carl H Backes Journal: Clin Perinatol Date: 2022-01-21 Impact factor: 3.430
Authors: Michael T Kuntz; Steven J Staffa; Dionne Graham; David Faraoni; Philip Levy; James DiNardo; Nicola Maschietto; Viviane G Nasr Journal: J Am Heart Assoc Date: 2021-12-31 Impact factor: 6.106
Authors: Rachel Reo; Erin Van Pelt; Casey Lovelace; Anne Eshelman; Brian Beckman; Joanne Chisolm; Brian Boe; Carl Backes; Clifford L Cua Journal: Cardiol Ther Date: 2022-07-03